Ascorbic acid deficiency in porphyria cutanea tarda

Journal of Laboratory and Clinical Medicine

Volumn 130, Issue 2, 1997, Pages 197-201

  Sinclair, Peter R ^a   Gorman, Nadia ^b   Shedlofsky, Steven I ^b   Honsinger, Charles P ^b   Sinclair, Jacqueline F ^b   Karagas, Margaret R ^b   Anderson, Karl E ^b  

^a VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031214425     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90096-2     Document Type: Article

References (17)

1. Anderson KE. The porphyrias. In: Zakim D, Boyer TD, editors. Hepatology. 3rd ed. Philadelphia: WB Saunders, 1996:417-63.
2. Elder GH. Porphyria cutanea tarda: a multifactorial disease, In: Champion RH, Pye RJ, editors. Recent advances in dermatology 8. Edinburgh: Churchill Livingstone, 1990:55-69.
3. Elder GH, Roberts AG. Uroporphyrinogen decarboxylase. J Bioenerg Biomembr 1995;27:207-14.
4. Sinclair P, Gorman N, Walton HS, Bernent WJ, Jacobs JM, Sinclair JF. Ascorbic acid inhibition of cytochrome P450-catalyzed uroporphyrin accumulation. Arch Biochem Biophys 1993;304:464-70.
5. Sinclair P, Gorman N, Sinclair JF, Walton HS, Bernent WJ, Lambrecht RW. Ascorbic acid inhibits chemically induced uroporphyria in ascorbate-requiring rats. Hepatology 1995; 22:565-72.
6. Fargion S, Piperno A, Cappellini MD, Sampietro M, Fracanzani AL, Romano R, et al. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 1992;16:1322-6.
7. Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A 1996;93:3704-9.
8. Berger J, Shepard D, Morrow F, Taylor AJ. Relationship between dietary intake and tissue levels of reduced and total vitamin C in the nonscorbutic guinea pig. J Nutr 1989;119: 734-40.
9. Jacob RA. Vitamin C. In: Roe J, editor. Modern nutrition in health and disease. Philadelphia: Lea & Febiger, 1994:432-48.
10. Wissel PS, Sordillo P, Anderson KE, Sassa S, Savillo RL, Kappas A. Porphyria cutanea tarda associated with the acquired immune deficiency syndrome. Am J Hematol 1987; 25:107-13.
11. Lynch SR, Seftel HC, Torrance JD, Charlton RW, Bothwell TH. Accelerated oxidative catabolism of ascorbic acid in siderotic Bantu. Am J Clin Nutr 1967;20:641-7.
12. Livrea MA, Tesoriere L, Pintaudi AM, Calabrese A, Maggio A, Freisleben H-J, et al. Oxidative stress and antioxidant status in β-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 1996;88:3608-14.
13. Ratnaike S, Blake D, Campbell D, Cowen P, Varigos G. Plasma ferritin as a guide to the treatment of porphyria cutanea tarda by venesection. Australas J Dermatol 1988;29: 3-7.
14. Butler MA, Lang NP, Young JF, Caporaso NE, Vineis P, Hayes RB, et al. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics 1992;2:116-27.
15. Lecomte E, Herbeth B, Pirollet P, Chancerelle Y, Arnaud J, Musse N, et al. Effect of alcohol consumption on blood antioxidant nutrients and oxidative stress indicators. Am J Clin Nutr 1994;60:255-61.
16. Rocchi E, Stella M, Cassanelli M, Borghi A, Nardella N, Seium Y, et al. Liposoluble vitamins and naturally occurring carotenoids in porphyria cutanea tarda. Eur J Clin Invest 1995;25:510-4.
17. Herbert V, Shaw S, Jayatilleke E. Vitamin C-driven free radical generation from iron. J Nutr 1996;126:1213S-20S.